Hong Mimi Zhou

This inventor holds 11 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Janssen Biotech, Inc., Centocor Ortho Biotech Inc., Janssen Pharmaceutica Nv. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Mimi Zhou. Retrieved from https://idiyas.com/inventor/hong-mimi-zhou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 4)

% Patents Active = 54.5

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 7.8

ph-index = 4

Forward Citations = 37(Granted Patents)

Location History:

Sand Diego, CA (US) (2020)
San Diego, CA (US) (2012 - 2023)

Company Filing History:

8 out of 433

Janssen Biotech, Inc.

patents

2 out of 31

Centocor Ortho Biotech Inc.

patents

1 out of 2,101

Janssen Pharmaceutica Nv

patents

Years Active: 2012-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11746157 - PSMA binding agents and uses thereof (2023-09-05),

2. 11421037 - Nucleic acids encoding anti-CD154 antibodies (2022-08-23),

3. 11299545 - Anti-HLA-C antibodies and uses thereof (2022-04-12),

4. 10864268 - CD47 antibodies, methods, and uses (2020-12-15),

5. 10669343 - Anti-CD154 antibodies and methods of using them (2020-06-02),

6. 10544229 - Agonistic antibodies specifically binding CD40 and methods of use (2020-01-28),

7. 8999333 - Human tissue factor antibody and uses thereof (2015-04-07),

8. 8951525 - Human tissue factor antibody and uses thereof (2015-02-10),

9. 8722044 - Human tissue factor antibody and uses thereof (2014-05-13),

10. 8399630 - Engineered anti-IL-13 antibodies, compositions, methods and uses (2013-03-19),

11. 8323646 - Engineered anti-IL-13 antibodies, compositions, methods and uses (2012-12-04),

Title: Innovations of Hong Mimi Zhou

Introduction

Hong Mimi Zhou is a prominent inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, holding a total of 10 patents. His work primarily focuses on developing innovative binding agents and antibodies that have potential applications in medical treatments.

Latest Patents

Among his latest patents are the PSMA binding agents and their uses. This invention relates to antibodies that specifically bind to PSMA or PSMA and CD3, along with polynucleotides encoding these antibodies or fragments. Additionally, he has developed nucleic acids encoding anti-CD154 antibodies, which are antagonistic antibodies that specifically bind to CD154, along with methods for making and using these inventions.

Career Highlights

Hong Mimi Zhou has worked with notable companies in the biotechnology sector, including Janssen Biotech, Inc. and Centocor Ortho Biotech Inc. His experience in these organizations has allowed him to advance his research and contribute to significant innovations in the field.

Collaborations

Some of his notable coworkers include Alexey Teplyakov and Ellen Chi, who have collaborated with him on various projects.

Conclusion

Hong Mimi Zhou's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.